468074292	468074292	CD	B-NP	O
|	|	JJ	I-NP	O
T	T	NN	I-NP	O
|	|	VBD	B-VP	O
20694051	20694051	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
410543	410543	CD	B-NP	O
|	|	CC	I-NP	O
10/29/2002	10/29/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HEPATIC	HEPATIC	NNP	I-NP	I-protein
ENCEPHALOPATHY	ENCEPHALOPATHY	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/18/2002	11/18/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/1/2002	9/1/2002	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
57-year-old	57-year-old	JJ	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
a	a	DT	B-NP	O
massive	massive	JJ	I-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
bleed	bleed	NN	I-NP	O
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
of	of	IN	B-PP	O
2001	2001	CD	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Gosroa	Gosroa	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Services	Services	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
TIPS	TIPS	NN	I-NP	O
procedure	procedure	NN	I-NP	O
which	which	WDT	B-NP	O
failed	fail	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
proceeded	proceed	VBD	B-VP	O
to	to	TO	I-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
surgery	surgery	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
splenorenal	splenorenal	JJ	I-NP	O
shunt	shunt	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Tonla	Tonla	NNP	I-NP	O
Liha	Liha	NNP	I-NP	O
Measemillr	Measemillr	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
And	And	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2002	2002	CD	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
complicating	complicate	VBG	I-NP	O
course	course	NN	I-NP	O
with	with	IN	B-PP	O
encephalopathy	encephalopathy	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
lactulose	lactulose	NN	B-NP	O
and	and	CC	O	O
discharged	discharge	VBN	B-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
complications	complication	NNS	B-NP	O
with	with	IN	B-PP	O
infections	infection	NNS	B-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
fairly	fairly	RB	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
ammonia	ammonia	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
high	high	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
highest	high	JJS	I-NP	O
was	be	VBD	B-VP	O
196	196	CD	B-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2002	2002	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
had	have	VBD	I-VP	O
increased	increase	VBN	I-VP	O
confusion	confusion	NN	B-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
abdominal	abdominal	JJ	I-NP	O
girth	girth	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
daughters	daughter	NNS	I-NP	O
went	go	VBD	B-VP	O
in	in	RB	B-ADVP	O
to	to	TO	B-VP	O
visit	visit	VB	I-VP	O
her	her	PRP$	B-NP	O
today	today	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
completely	completely	RB	I-VP	O
disoriented	disorient	VBN	I-VP	O
,	,	,	O	O
complaining	complain	VBG	B-VP	O
of	of	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
daughters	daughter	NNS	I-NP	O
also	also	RB	B-ADVP	O
report	report	VBP	B-VP	O
subjective	subjective	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
and	and	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
94/60	94/60	CD	B-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	O
99.2	99.2	CD	I-NP	O
.	.	.	O	O

Per	Per	IN	B-PP	O
the	the	DT	B-NP	O
daughters	daughter	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
diet	diet	NN	I-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
followed	follow	VBN	I-VP	O
at	at	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
eating	eat	VBG	I-VP	O
hot	hot	JJ	B-NP	O
dogs	dog	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
given	give	VBN	I-VP	O
benzodiazepines	benzodiazepine	NNS	B-NP	O
for	for	IN	B-PP	O
sleep	sleep	NN	B-NP	O
,	,	,	O	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
60-75	60-75	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
Oxazepam	Oxazepam	NNP	B-NP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
confusion	confusion	NN	B-NP	O
and	and	CC	O	O
more	more	RBR	B-ADVP	O
acutely	acutely	RB	I-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
arrival	arrival	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
120s	120s	CD	I-NP	O
,	,	,	I-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
febrile	febrile	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
and	and	CC	I-NP	O
ampicillin	ampicillin	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Gastrointestinal	Gastrointestinal	JJ	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Cirrhosis	Cirrhosis	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
grade	grade	NN	B-NP	O
4	4	CD	I-NP	O
esophageal	esophageal	JJ	I-NP	O
varices	varix	NNS	I-NP	O
,	,	,	O	O
encephalopathy	encephalopathy	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
a	a	DT	B-NP	O
frontal	frontal	JJ	I-NP	O
craniotomy	craniotomy	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
a	a	DT	B-NP	O
motor	motor	NN	I-NP	O
vehicle	vehicle	NN	I-NP	O
accident	accident	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
subdural	subdural	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
,	,	,	O	O
peptic	peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
TRANSFER	TRANSFER	NN	I-NP	O
:	:	:	O	O
Spironolactone	Spironolactone	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
olanzapine	olanzapine	NN	B-NP	O
unknown	unknown	JJ	I-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
completed	complete	VBN	I-VP	O
her	her	PRP$	B-NP	O
course	course	NN	I-NP	O
for	for	IN	B-PP	O
Clostridium	Clostridium	NNP	B-NP	O
difficile	difficile	NN	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
and	and	CC	O	O
Atrovent	Atrovent	JJ	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
,	,	,	O	O
lactulose	lactulose	RB	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Serax	Serax	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
Duragesic	Duragesic	JJ	B-NP	O
patch	patch	NN	I-NP	O
,	,	,	O	O
Neomycin	Neomycin	NN	B-NP	O
2	2	CD	B-NP	O
grams	gram	NNS	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
,	,	,	O	O
Oxazepam	Oxazepam	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
and	and	CC	O	O
15	15	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
SOCIAL	SOCIAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
daughters	daughter	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
remarkable	remarkable	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
for	for	IN	B-PP	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
pack	pack	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
recently	recently	RB	B-ADVP	O
quit	quit	RB	I-ADVP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Non-contributory	Non-contributory	JJ	B-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
101.1	101.1	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
99-120	99-120	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
94-149/55	94-149/55	CD	I-NP	O
-71	-71	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
well-nourished	well-nourished	JJ	I-NP	O
,	,	,	I-NP	O
well-developed	well-developed	JJ	I-NP	O
lady	lady	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
confused	confuse	VBN	I-VP	O
and	and	CC	I-VP	O
agitated	agitate	VBN	I-VP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
icteric	icteric	JJ	B-NP	O
sclera	sclera	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NNS	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Jugular	Jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
bowel	bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
distended	distend	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
tenderness	tenderness	NN	B-NP	O
on	on	IN	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

RECTAL	RECTAL	NN	B-NP	O
:	:	:	O	O
Guaiac-positive	Guaiac-positive	JJ	B-ADJP	O
per	per	IN	B-PP	O
emergency	emergency	NN	B-NP	O
department	department	NN	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
had	have	VBD	B-VP	O
erythema	erythema	NN	B-NP	O
,	,	,	O	O
painful	painful	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
touch	touch	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
warmth	warmth	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
cords	cord	NNS	I-NP	O
.	.	.	O	O

NEUROLOGICAL	NEUROLOGICAL	NN	B-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
asterixis	asterixis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
to	to	TO	B-PP	O
person	person	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
to	to	TO	B-PP	O
time	time	NN	B-NP	O
and	and	CC	O	O
confused	confuse	VBD	B-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
place	place	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
carry	carry	VB	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
conversation	conversation	NN	I-NP	O
and	and	CC	O	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
attentive	attentive	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
strength	strength	NN	I-NP	O
was	be	VBD	B-VP	O
5/5	5/5	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
sensation	sensation	NN	I-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
:	:	:	O	O
Laboratory	Laboratory	NN	B-NP	O
data	datum	NNS	I-NP	O
was	be	VBD	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
130	130	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.9	4.9	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
102	102	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
17	17	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-protein
9	9	CD	I-NP	I-protein
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.8	0.8	CD	I-NP	O
and	and	CC	O	O
glucose	glucose	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ALT	ALT	NN	I-NP	B-protein
was	be	VBD	B-VP	O
16	16	CD	B-NP	O
,	,	,	O	O
AST	AST	NN	B-NP	O
72	72	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
118	118	CD	I-NP	O
,	,	,	O	O
amylase	amylase	NN	B-NP	O
15	15	CD	I-NP	O
and	and	CC	O	O
lipase	lipase	NN	B-NP	O
33	33	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ammonia	ammonia	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
45	45	CD	B-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	O
3.2	3.2	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
2.4	2.4	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
29.1	29.1	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.4	1.4	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
abscess	abscess	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
obstruction	obstruction	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Gastrointestinal	Gastrointestinal	NNP	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
confusing	confusing	JJ	I-NP	O
picture	picture	NN	I-NP	O
for	for	IN	B-PP	O
increased	increase	VBN	B-NP	O
abdominal	abdominal	JJ	I-NP	O
girth	girth	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
the	the	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
very	very	RB	B-NP	O
little	little	JJ	I-NP	O
ascites	ascite	NNS	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
examination	examination	NN	B-NP	O
,	,	,	O	O
little	little	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
got	get	VBD	B-VP	O
a	a	DT	B-NP	O
paracentesis	paracentesis	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
peritonitis	peritonitis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
cefotaxime	cefotaxime	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
peritonitis	peritonitis	NN	I-NP	O
,	,	,	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
lactulose	lactulose	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
diuretics	diuretic	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
much	much	RB	B-VP	O
improved	improve	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
and	and	CC	B-PP	O
after	after	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
infectious	infectious	JJ	I-NP	O
picture	picture	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
see	see	VBP	B-VP	O
below	below	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
incredibly	incredibly	RB	B-ADVP	O
well	well	RB	I-ADVP	O
with	with	IN	B-PP	O
spironolactone	spironolactone	NN	B-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
her	her	PRP$	B-NP	O
beta	beta	NN	I-NP	O
blocker	blocker	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hypotension	hypotension	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

A	A	DT	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

I	I	PRP	B-NP	O
appreciate	appreciate	VBP	B-VP	O
their	their	PRP$	B-NP	O
input	input	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
recommend	recommend	VBP	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Transplant	Transplant	NN	I-NP	O
Team	Team	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
the	the	DT	B-NP	O
Transplant	Transplant	NNP	I-NP	O
Team	Team	NNP	I-NP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
2002	2002	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
begin	begin	VB	B-VP	O
to	to	TO	I-VP	O
get	get	VB	I-VP	O
work-up	work-up	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
liver	liver	NN	I-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
-RRB-	-RRB-	:	O	O
Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
peritonitis	peritonitis	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
4/4	4/4	CD	B-NP	O
bottles	bottle	NNS	I-NP	O
with	with	IN	B-PP	O
gram	gram	NN	B-NP	O
positive	positive	JJ	I-NP	O
cocci	coccus	NNS	I-NP	O
in	in	IN	B-PP	O
pairs	pair	NNS	B-NP	O
which	which	WDT	B-NP	O
speciated	speciate	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
Streptococcus	Streptococcus	NNP	B-NP	O
Group	Group	NNP	I-NP	O
B.	B.	NNP	I-NP	O
Therefore	Therefore	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
tailored	tailor	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
nafcillin	nafcillin	NN	B-NP	O
intravenously	intravenously	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
placed	place	VBN	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
with	with	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	B-protein
penicillin	penicillin	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
doing	do	VBG	I-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
with	with	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
erythema	erythema	NN	I-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
Service	Service	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

I	I	PRP	B-NP	O
appreciate	appreciate	VBP	B-VP	O
their	their	PRP$	B-NP	O
input	input	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
suggested	suggest	VBD	B-VP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	B-protein
penicillin	penicillin	NN	I-NP	I-protein
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cardiovascular/hematology	Cardiovascular/hematology	NNP	I-NP	O
:	:	:	O	O
Given	Give	VBN	B-VP	O
the	the	DT	B-NP	O
swelling	swelling	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
leg	leg	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
ultrasounds	ultrasound	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
clot	clot	NN	B-NP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Psychiatry	Psychiatry	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
very	very	RB	I-VP	O
confused	confuse	VBN	I-VP	O
,	,	,	O	O
most	most	RBS	B-NP	O
likely	likely	JJ	I-NP	O
delirium	delirium	NN	I-NP	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
input	input	NN	I-NP	O
was	be	VBD	B-VP	O
greatly	greatly	RB	I-VP	O
appreciated	appreciate	VBN	I-VP	O
.	.	.	O	O

Another	Another	DT	B-NP	O
reason	reason	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
confusion	confusion	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
getting	get	VBG	I-VP	O
much	much	JJ	B-NP	O
benzodiazepines	benzodiazepine	NNS	I-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
before	before	IN	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
her	her	PRP$	B-NP	O
benzodiazepines	benzodiazepine	NNS	I-NP	O
and	and	CC	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
olanzapine	olanzapine	NN	B-NP	O
and	and	CC	O	O
titrated	titrate	VBD	B-VP	O
up	up	RP	B-PRT	O
as	as	RB	O	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
highly	highly	RB	B-ADVP	O
recommend	recommend	VBP	B-VP	O
avoiding	avoid	VBG	B-NP	O
benzodiazepines	benzodiazepine	NNS	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
continue	continue	VBP	B-VP	O
with	with	IN	B-PP	O
olanzapine	olanzapine	NN	B-NP	O
which	which	WDT	B-NP	O
can	can	MD	B-VP	O
take	take	VB	I-VP	O
p.r.n.	p.r.n.	RB	B-ADVP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Vascular	Vascular	NNP	I-NP	O
:	:	:	O	O
Vascular	Vascular	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
followed	follow	VBD	B-VP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
deemed	deem	VBD	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
splenorenal	splenorenal	JJ	I-NP	O
shunt	shunt	NN	I-NP	O
was	be	VBD	B-VP	O
working	work	VBG	I-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
leak	leak	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
and	and	CC	I-NP	O
finishing	finishing	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
requested	request	VBN	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
myself	myself	PRP	B-NP	O
.	.	.	O	O

I	I	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
her	her	PRP	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
I	I	PRP	B-NP	O
have	have	VBP	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
olanzapine	olanzapine	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
PM	PM	NN	I-NP	O
and	and	CC	O	O
olanzapine	olanzapine	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
,	,	,	O	O
Atrovent	Atrovent	JJ	B-NP	O
inhalers	inhaler	NNS	I-NP	O
,	,	,	O	O
Azmacort	Azmacort	NN	B-NP	O
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
million	million	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
intravenously	intravenously	RB	B-ADVP	O
q.	q.	VBP	B-VP	O
4h	4h	NN	B-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
a	a	DT	B-NP	O
complete	complete	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Nico-Derm	Nico-Derm	NN	B-NP	O
14	14	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
topical	topical	JJ	B-ADJP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
if	if	IN	B-SBAR	O
her	her	PRP$	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
lactulose	lactulose	RB	B-NP	O
30	30	CD	I-NP	O
ml	ml	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Motrin	Motrin	NNP	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NN	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
SHIRLEY	SHIRLEY	NNP	B-NP	O
SANDBURG	SANDBURG	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SH43	SH43	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TOMAS	TOMAS	NNP	B-NP	O
H.	H.	NNP	I-NP	O
FRAZELL	FRAZELL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
JZ62	JZ62	NNP	I-NP	O
AZ744/280222	AZ744/280222	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
2159	2159	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

QYEULV8R19	QYEULV8R19	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/12/02	10/12/02	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/12/02	10/12/02	CD	B-NP	O

